Article
In this video from The American Journal of Pharmacy Benefits, Aimee Tharaldson, PharmD, discusses some of the current trends in the specialty pharmacy market and notes that the pipeline for cancer drugs is likely to be the most robust.
In this video from The American Journal of Pharmacy Benefits, Aimee Tharaldson, PharmD, discusses some of the current trends in the specialty pharmacy market and notes that the pipeline for cancer drugs is likely to be the most robust.
Also see: Aimee Tharaldson, PharmD, Discusses the Biosimilar Pathway
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa